tiprankstipranks
Trending News
More News >
Shield Therapeutics (DE:1JS)
:1JS
Germany Market

Shield Therapeutics (1JS) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Shield Therapeutics’s (1JS) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Shield Therapeutics is a Sell.
Shield Therapeutics’s (1JS) 20-Day exponential moving average is 0.03, while Shield Therapeutics’s (1JS) share price is <€0.1, making it a Buy.
Shield Therapeutics’s (1JS) 50-Day exponential moving average is 0.03, while Shield Therapeutics’s (1JS) share price is <€0.1, making it a Buy.

Shield Therapeutics (1JS) Pivot Points

Jun 27, 2025, 04:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Fibonacci
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (1JS) Moving Averages

Jun 27, 2025, 04:23 AM
Period
Simple
Exponential
MA5
0.03Buy
0.03Buy
MA10
0.03Buy
0.03Buy
MA20
0.03Buy
0.03Buy
MA50
0.03Buy
0.03Buy
MA100
0.03Sell
0.03Sell
MA200
0.04Sell
0.03Sell
Shield Therapeutics’s (1JS) 10-Day exponential moving average is 0.03, while Shield Therapeutics’s (1JS) share price is <€0.1, making it a Buy.
Shield Therapeutics’s (1JS) 100-Day exponential moving average is 0.03, while Shield Therapeutics’s (1JS) share price is <€0.1, making it a Sell.
Shield Therapeutics’s (1JS) stock price is <€0.1 and Shield Therapeutics’s (1JS) 50-day simple moving average is 0.03, creating a Buy signal.
Shield Therapeutics’s (1JS) stock price is <€0.1 and Shield Therapeutics’s (1JS) 100-day simple moving average is 0.03, creating a Sell signal.
Shield Therapeutics’s (1JS) stock price is <€0.1 and Shield Therapeutics’s (1JS) 200-day simple moving average is 0.04, creating a Sell signal.

Shield Therapeutics (1JS) Technical Indicators

Jun 27, 2025, 04:23 AM
Name
Value
Implied Action
RSI (14)
53.74
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
72.72
Sell
Williams %R
0.00
Buy
CCI (14)
80.87
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
86.09
Buy
ROC
7.41
Buy
Shield Therapeutics’s (1JS) Relative Strength Index (RSI) is 53.74, creating a Neutral signal.
Shield Therapeutics’s (1JS) Trend Strength Indicator (ADX) is 72.72, creating a Sell signal.
Shield Therapeutics’s (1JS) Commodity Channel Index (CCI) is 80.87, creating a Neutral signal.
Shield Therapeutics’s (1JS) Price Rate of Change (ROC) is 7.41, creating a Buy signal.

FAQ

Is 1JS a Buy, Hold, or Sell?
Based on 1JS’s technical indicators, 1JS is a Buy.
    What is 1JS’s RSI (14)?
    1JS’s RSI (14) is 53.74, which suggests 1JS is a Neutral.
      What is 1JS’s MACD?
      1JS’s MACD is <0.01, which suggests 1JS is a Sell.
        What is 1JS’s 5-day moving average?
        1JS’s 5-day moving average is 0.03, which suggests 1JS is a Buy.
          What is 1JS’s 20-day moving average?
          1JS 20-day moving average is 0.03, which suggests 1JS is a Buy.
            What is 1JS’s 50-day moving average?
            1JS’s 50-day moving average is 0.03, which suggests 1JS is a Buy.
              What is 1JS’s 200-day moving average?
              1JS’s 200-day moving average is 0.04, which suggests 1JS is a Sell.
                What is 1JS’s Williams % R (14)?
                1JS’s Williams % R (14) is 0.00, which suggests 1JS is a Buy.
                  What is 1JS’s CCI (14)?
                  1JS’s CCI (14) is 80.87, which suggests 1JS is a Neutral.
                    What is the share price of Shield Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis